Cellular re- and de-programming by microenvironmental memory: Why short TGF-β1 pulses can have long effects

Fibrogenesis and Tissue Repair

Volumn 6, Issue 1, 2013, Pages

  Tan, Ariel Bing Shi ^a,b   Kress, Sebastian ^b,c   Castro, Leticia ^d   Sheppard, Allan ^d   Raghunath, Michael ^b,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cytokine; Extracellular matrix; Fibrosis; Kinetics; Memory; Phenotype; Pulses; Transforming growth factor beta 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELLULAR DEPROGRAMMING; CELLULAR REPROGRAMMING; CONTROLLED STUDY; EPIGENETICS; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; FETUS; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSCRIPTION; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84879039593     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-6-12     Document Type: Article

References (54)

1. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008, 3:8. 10.1186/1750-1172-3-8, 2330030, 18366757.
2. Pol S, Vallet-Pichard A, Corouge M, Mallet VO. Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contrib Nephrol 2012, 176:1-9.
3. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol 1995, 103:466-471.
4. Tang L, Hu W. Molecular determinants of biocompatibility. Expert Rev Med Devices 2005, 2:493-500. 10.1586/17434440.2.4.493, 16293087.
5. Thevenot P, Hu W, Tang L. Surface chemistry influences implant biocompatibility. Curr Top Med Chem 2008, 8:270-280. 10.2174/156802608783790901, 3230929, 18393890.
6. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100. 10.1016/j.smim.2007.11.004, 2327202, 18162407.
7. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003, 28:105-112. 10.1247/csf.28.105, 12808230.
8. Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 2006, 108:2893-2896. 10.1182/blood-2006-04-016600, 16840726.
9. Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int J Exp Pathol 2011, 92:143-150. 10.1111/j.1365-2613.2011.00775.x, 3101487, 21554437.
10. Kis K, Liu X, Hagood JS. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 2011, 13:e27.
11. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001, 159:1009-1020. 10.1016/S0002-9440(10)61776-2, 1850455, 11549593.
12. Lee KW, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J Royal Soc Interface 2011, 8:153-170.
13. Yang L, Qiu CX, Ludlow A, Ferguson MW, Brunner G. Active transforming growth factor-beta in wound repair: determination using a new assay. Am J Pathol 1999, 154:105-111. 10.1016/S0002-9440(10)65256-X, 1868600, 9916924.
14. Flanagan CA, Millar RP, Illing N. Advances in understanding gonadotrophin-releasing hormone receptor structure and ligand interactions. Rev Reprod 1998, 2:113-120.
15. Veldhuis JD. Ultradian rhythms from molecules to mind. Pulsatile Hormone Secretion (Chapter 10): Mechanisms, Significance and Evaluation 2008, 229-248. New York: Springer Science + Business Media BV, Lloyd D, Rossi E.
16. Hsieh SC, Graves DT. Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory. J Cell Biochem 1998, 69:169-180. 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q, 9548564.
17. Jones SM, Kazlauskas A. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 2001, 3:165-172. 10.1038/35055073, 11175749.
18. Toledo-Aral JJ, Brehm P, Halegoua S, Mandel G. A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction. Neuron 1995, 14:607-611. 10.1016/0896-6273(95)90317-8, 7695907.
19. Chen C, Loe F, Blocki A, Peng Y, Raghunath M. Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies. Adv Drug Deliv Rev 2011, 63:277-290. 10.1016/j.addr.2011.03.003, 21392551.
20. Duchesne L, Octeau V, Bearon RN, Beckett A, Prior IA, Lounis B, Fernig DG. Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate. PLoS Biol 2012, 10:e1001361. 10.1371/journal.pbio.1001361, 3398970, 22815649.
21. Zi Z, Feng Z, Chapnick DA, Dahl M, Deng D, Klipp E, Moustakas A, Liu X. Quantitative analysis of transient and sustained transforming growth factor-β signaling dynamics. Mol Syst Biol 2011, 7:492. 3130555, 21613981.
22. Inman GJ, Nicolás FJ, Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGFβ receptor activity. Mol Cell 2002, 10:283-294. 10.1016/S1097-2765(02)00585-3, 12191474.
23. Zeisberg EM, Zeisberg M. The role of promoter hypermethylation in fibroblast activation and fibrogenesis. J Pathol 2013, 229:264-273. 10.1002/path.4120, 23097091.
24. Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006, 54:2271-2279. 10.1002/art.21948, 16802366.
25. Kramer M, Dees C, Huang J, Schlottmann I, Palumbo-Zerr K, Zerr P, Gelse K, Beyer C, Distler A, Marquez VE, Distler O, Schett G, Distler JH. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann Rheum Dis 2013, 72:614-620. 10.1136/annrheumdis-2012-201615, 22915621.
26. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression?. J Theor Biol 1982, 99:31-68. 10.1016/0022-5193(82)90388-5, 6892044.
27. Bornstein P, McPherson J, Sage H. Synthesis and secretion of structural macromolecules by endothelial cells in culture. Pathobiology of the Endothelial Cell 1982, 215-228. New York: Academic Press, Nossel HL, Vogel HJ.
28. Askari JA, Buckley PA, Mould AP, Humphries MJ. Linking integrin conformation to function. J Cell Sci 2009, 122:165-170. 10.1242/jcs.018556, 2714414, 19118208.
29. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011, 19:134-148. 10.1111/j.1524-475X.2011.00673.x, 3051353, 21362080.
30. Taipale J, Saharinen J, Hedman K, Keski-Oja J. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 1996, 44:875-889. 10.1177/44.8.8756760, 8756760.
31. Raghunath M, Tschödrich-Rotter M, Sasaki T, Meuli M, Chu ML, Timpl R. Confocal laser scanning analysis of the association of fibulin-2 with fibrillin-1 and fibronectin define different stages of skin regeneration. J Invest Dermatol 1999, 112:97-101. 10.1046/j.1523-1747.1999.00483.x, 9886271.
32. Mangasser-Stephan K, Gartung C, Lahme B, Gressner AM. Expression of isoforms and splice variants of the latent transforming growth factor beta binding protein (LTBP) in cultured human liver myofibroblasts. Liver 2001, 21:105-113. 10.1034/j.1600-0676.2001.021002105.x, 11318979.
33. Li W, He H, Chen YT, Hayashida Y, Tseng SC. Reversal of myofibroblasts by amniotic membrane stromal extract. J Cell Physiol 2008, 215:657-664. 10.1002/jcp.21345, 2839917, 18181149.
34. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by TGFβ1. J Cell Biol 1998, 142:873-881. 10.1083/jcb.142.3.873, 2148176, 9700173.
35. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007, 179:1311-1323. 10.1083/jcb.200704042, 2140013, 18086923.
36. Malmström J, Westergren-Thorsson G, Marko-Varga G. A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis 2001, 22:1776-1784. 10.1002/1522-2683(200105)22:9<1776::AID-ELPS1776>3.0.CO;2-H, 11425232.
37. Birk DE, Trelstad RL. Extracellular compartments in matrix morphogenesis: collagen fibril, bundle, and lamellar formation by corneal fibroblasts. J Cell Biol 1984, 99:2024-2033. 10.1083/jcb.99.6.2024, 2113579, 6542105.
38. Vassiliadis E, Veidal SS, Simonsen H, Larsen DV, Vainer B, Chen X, Zheng Q, Karsdal MA, Leeming DJ. Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis. Biomarkers 2011, 16:426-433. 10.3109/1354750X.2011.584131, 21612338.
39. Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000, 41:1-27. 10.3109/03008200009005638, 10826705.
40. Szauter KM, Cao T, Boyd CD, Csiszar K. Lysyl oxidase in development, aging and pathologies of the skin. Pathol Biol (Paris) 2005, 53:448-456.
41. Baker AM, Bird D, Lang G, Cox TR, Erler JT. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene 2012, 32:1863-1868.
42. Hinz B. Tissue stiffness, latent TGF-β1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 2009, 11:120-126. 10.1007/s11926-009-0017-1, 19296884.
43. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906. 10.1016/j.cell.2009.10.027, 2788004, 19931152.
44. Jones C, Ehrlich HP. Fibroblast expression of α-smooth muscle actin, α2β1 integrin and αvβ3 integrin: influence of surface rigidity. Exp Mol Pathol 2011, 91:394-399. 10.1016/j.yexmp.2011.04.007, 3139750, 21530503.
45. Olsen AL, Bloomer SA, Chan EP, Gaça MD, Georges PC, Sackey B, Uemura M, Janmey PA, Wells RG. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 2011, 301:110-118.
46. Piechocka IK, van Oosten AS, Breuls RG, Koenderink GH. Rheology of heterotypic collagen networks. Biomacromolecules 2011, 12:2797-2805. 10.1021/bm200553x, 21671664.
47. Sohara N, Znoyko I, Levy MT, Trojanowska M, Reuben A. Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J Hepatol 2002, 37:214-221. 10.1016/S0168-8278(02)00103-4, 12127426.
48. Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol 2011, 1:188-202.
49. Raghunath M, Steinmann B, Delozier-Blanchet C, Extermann P, Superti-Furga A. Prenatal diagnosis of collagen disorders by direct biochemical analysis of chorionic villus biopsies. Pediatr Res 1994, 36:441-448. 10.1203/00006450-199410000-00005, 7816518.
50. Chen CZC, Peng YX, Wang ZB, Fish PV, Kaar JL, Koepsel RR, Russell AJ, Lareu RR, Raghunath M. The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br J Pharmacol 2009, 158:1196-1209. 10.1111/j.1476-5381.2009.00387.x, 2782330, 19785660.
51. Lareu RR, Subramhanya KH, Peng Y, Benny P, Chen C, Wang Z, Rajagopalan R, Raghunath M. Collagen matrix deposition is dramatically enhanced in vitro when crowded with charged macromolecules: the biological relevance of the excluded volume effect. FEBS Lett 2007, 581:2709-2714. 10.1016/j.febslet.2007.05.020, 17531987.
52. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 2007, 35:e119. 10.1093/nar/gkm662, 2094090, 17855397.
53. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002, 12:996-1006. 186604, 12045153.
54. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431. 10.1093/bioinformatics/18.11.1427, 12424112.